Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04668326 · ClinicalTrials.gov registry record · NA
Mobile Manual Standing Wheelchair for SCI
A NA study of Spinal Cord Injuries and Disorders, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT04668326: Active NA study of Spinal Cord Injuries and Disorders, sponsored by VA Office of Research and Development.
NCT04668326 is a NA study of Spinal Cord Injuries and Disorders that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04668326, a NA study of Spinal Cord Injuries and Disorders, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
People with spinal cord injuries (SCI) are particularly prone to complications from excessive sitting, because many are not able to stand without support. Excessive sitting after SCI is believed to contribute to pressure injuries, pain, osteoporosis, joint stiffness, spasticity, and worsening bowel and bladder function. The VA has developed, patented, and licensed a mobile manual standing wheelchair (MMSW), and the investigators believe the key feature of being able to wheel around while in a standing position will dramatically change how paralyzed Veterans function in their home and community. If this expanded utility is realized, persons with SCI may naturally spend more time standing and less time sitting. To test these ideas, Veterans with SCI will be randomized to using one of two manual standing wheelchairs at home and in the community for two months.
Primary Outcome
The Wheelchair Outcome Measure (WhOM) will be slightly modified to ask users to provide participation goals in the home and community in the context of standing devices/wheelchairs as opposed to wheelchairs alone. The WhOM collects activities that are goals for participation and then has the participant rank the importance and satisfaction with each activity. The rankings allow a quantitative score to be calculated for comparison. The WhOM was chosen to represent the concept of "utility" because
Conditions Studied
Interventions
- DEVICE Manual Standing Wheelchair
- DEVICE Mobile Manual Standing Wheelchair
Study Locations (2)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Minnesota
- Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT04668326 still lists
NCT04668326 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Spinal Cord Injuries and Disorders appearing as the primary indexed condition, and to 2 interventions - of which Manual Standing Wheelchair is the first listed.
NCT04668326 reports a single indexed study location in California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT04668326 about?
NCT04668326 is a clinical study titled "Mobile Manual Standing Wheelchair for SCI". People with spinal cord injuries (SCI) are particularly prone to complications from excessive sitting, because many are not able to stand without support. Excessive sitting after SCI is believed to contribute to pressure injuries, pain, osteoporosis, joint stiffness, spasticity, and worsening bowel ...
What is the current status of trial NCT04668326?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-05-01. Estimated completion is 2026-03-31.
What conditions does trial NCT04668326 study?
This clinical trial studies the following conditions: Spinal Cord Injuries and Disorders.
What interventions are being tested in trial NCT04668326?
The interventions under investigation include: Manual Standing Wheelchair (DEVICE), Mobile Manual Standing Wheelchair (DEVICE).
Who is sponsoring clinical trial NCT04668326?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04668326 being conducted?
This trial has 2 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries and Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04668326's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI